
Antibodies, also known as immunoglobulins, are like the body's own defense soldiers made by our immune system to fight off invaders called antigens, which can be viruses or bacteria. These protein soldiers do more than just protect us from illnesses; they are also helpful in scientific research and medical tests because they can bind very specifically to certain molecules we want to study.
The journey from an immune response to a research tool involves preparing antigens, immunizing animals, and generating antibodies that are then meticulously collected and purified for research purposes, reflecting key principles in antibody production. This process is pivotal for scientists aiming to develop probes or therapeutic agents with high precision.
Antibody Production: A meticulous process that starts with the preparation of immunogens and ends with the generation of antibodies, increasingly complemented by recombinant production approaches that allow precise control over antibody expression.
Purification Techniques: From simple precipitation to sophisticated affinity chromatography, the purification process ensures that antibodies are isolated with the required purity for their intended use.
Antibody Modification: With purified antibodies, the next steps may include fragmentation, labeling, and immobilization. These modifications tailor antibodies for specific applications, from enhancing the clarity of cellular imaging to increasing the sensitivity of diagnostic tests.1
Antibody Fragmentation: Tailoring antibodies by removing non-essential parts, enhancing their utility in various experimental setups.
Labeling and Immobilization: Conjugating antibodies with detectable markers or attaching them to solid supports, broadening their application in scientific research.2
Harlow, E., & Lane, D. (1988). Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press.
Murphy, K., & Weaver, C. (9th Edition). Janeway's Immunobiology. Garland Science.
Two popular topics discussed at the 2026 BIO International Convention were devel……
AI is changing antibody discovery, but model performance depends on the quality ……
Antibody discovery has become increasingly sequence-rich. Display technologies, ……
Biointron, a leading contract research organization specializing in antibody dis……
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.
Biointron uses cookies and similar technologies to ensure proper website functionality, understand how visitors use our website, and improve our content and services. Necessary cookies are enabled by default.
By clicking “Accept All”, you agree to the use of all cookies, including analytics and optional cookies that help us understand website usage and improve user experience. By clicking “Reject Non-Essential”, only necessary cookies will be used.
You may manage or change your cookie preferences at any time by clicking “Cookie Settings” at the bottom of the website.
For more information about how we use cookies and process personal data, please review our Privacy Policy.



